Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $17.91

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received an average recommendation of “Hold” from the thirteen brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $16.4167.

Several brokerages have weighed in on XRAY. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Mizuho set a $13.00 price target on DENTSPLY SIRONA in a report on Friday. UBS Group reduced their price objective on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research note on Tuesday, October 28th. Finally, Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently modified their holdings of the stock. Arizona State Retirement System boosted its stake in DENTSPLY SIRONA by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock valued at $748,000 after purchasing an additional 807 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock worth $983,000 after buying an additional 861 shares in the last quarter. Gabelli Funds LLC raised its position in DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock worth $1,464,000 after buying an additional 1,000 shares during the last quarter. True Wealth Design LLC lifted its stake in DENTSPLY SIRONA by 49.7% during the 3rd quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after acquiring an additional 1,181 shares during the period. Finally, Sivia Capital Partners LLC boosted its holdings in shares of DENTSPLY SIRONA by 5.3% during the 3rd quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after acquiring an additional 1,293 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $11.18 on Thursday. The firm has a market capitalization of $2.23 billion, a P/E ratio of -2.36, a P/E/G ratio of 0.81 and a beta of 1.00. The stock has a fifty day moving average price of $12.98 and a two-hundred day moving average price of $14.48. DENTSPLY SIRONA has a 52-week low of $10.69 and a 52-week high of $20.59. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.